Fast Five Quiz: Influenza During the COVID-19 Pandemic

Michael Stuart Bronze, MD


November 15, 2022

Long-term aspirin therapy in patients younger than 19 years is better established as a risk for influenza complications than for COVID-19 complications. The use of aspirin has been found to prevent COVID-19 mortality. Metformin has shown efficacy in reducing influenza mortality. Neither osteoporosis nor gallbladder disease has been established as a significant risk factor for influenza complications.

Each of these also places patients at risk for influenza complications:

  • Age younger than 2 years

  • Asthma

  • Neurologic and neurodevelopmental conditions

  • Blood disorders

  • Chronic lung disease

  • Any endocrine disorders

  • Heart disease

  • Kidney disease

  • Liver disease

  • Metabolic disorders

According to the CDC, several specific conditions increase a person's risk for severe COVID-19 illness:

  • Chronic kidney disease

  • Type 2 diabetes

  • Chronic obstructive pulmonary disease

  • Obesity (body mass index of 30 or more)

  • Immunocompromised state from solid organ transplant

  • Serious heart conditions, such as heart failure, coronary artery disease, or cardiomyopathies

  • Sickle cell disease

Learn more about influenza.